Produkt
KlappentextThere exists a profound conflict at the heart of oncology drug development. The efficiency of the drug development process is falling, leading to higher costs per approved drug, at the same time personalised medicine is limiting the target market of each new medicine. Even as the global economic burden of cancer increases, the current paradigm in drug development is unsustainable. In this book, we discuss the development of techniques in machine learning for improving the efficiency of oncology drug development and delivering cost-effective precision treatment. We consider how to structure data for drug repurposing and target identification, how to improve clinical trials and how patients may view artificial intelligence.
Details
ISBN/GTIN978-1-78984-689-8
ProduktartBuch
EinbandartGebunden
Verlag
Erscheinungsjahr2020
Erscheinungsdatum09.09.2020
SpracheEnglisch
MasseBreite 185 mm, Höhe 266 mm, Dicke 18 mm
Gewicht634 g
Artikel-Nr.56880851
Rubriken
GenreMedizin